Tag Archives: Alabama Defense Lawyer

New Tele-Pharmacy Software Offers Face to Face Interaction Between Pharmacists and Patients – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Tele-Pharmacy Software Offers Face to Face Interaction Between Pharmacists and Patients – APhA submits compounding comments to FDA. – (866) 348-2889. Pharmacists are already one of the most accessible health … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Positive Topline Results Shown for Dupilumab in Phase 3 Trials in Patients with CRSwNP – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Positive Topline Results Shown for Dupilumab in Phase 3 Trials in Patients with CRSwNP – APhA submits compounding comments to FDA. – (866) 348-2889. All primary and secondary endpoints were met … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Increasing E-Cigarette Sales to Minors Prompts FDA to Crack Down – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Increasing E-Cigarette Sales to Minors Prompts FDA to Crack Down – APhA submits compounding comments to FDA. – (866) 348-2889. E-cigarettes can be beneficial tool for smoking cessation, but the use … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

New Pharmacogenomics Certificate Program Available to Pharmacists – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Pharmacogenomics Certificate Program Available to Pharmacists – APhA submits compounding comments to FDA. – (866) 348-2889. A new Pharmacogenomics Certificate is available through the American Society of Health-System Pharmacists (ASHP). … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Arthritis Prevalent with Depressive Symptoms in Older Adults – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Arthritis Prevalent with Depressive Symptoms in Older Adults – APhA submits compounding comments to FDA. – (866) 348-2889. A new study has found that arthritis is commonly reported in older … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Approves Second Drug Treatment for Polyneuropathy – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Approves Second Drug Treatment for Polyneuropathy – APhA submits compounding comments to FDA. – (866) 348-2889. The FDA has approved inotersen (Tegsedi, Akcea Therapeutics), an antisense oligonucleotide (ASO) that inhibits … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Study: In Utero Antiretroviral Exposure Possibly Linked to Neurologic Outcomes – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Study: In Utero Antiretroviral Exposure Possibly Linked to Neurologic Outcomes – APhA submits compounding comments to FDA. – (866) 348-2889. Efavirenz exposure (EVF) in utero is being linked to higher risk … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

CDC: Workplace Initiatives Lead to Increased Flu Vaccination – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF CDC: Workplace Initiatives Lead to Increased Flu Vaccination – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA have approved sarecycline (Seysara, Paratek and Almirall) for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

CDC: Workplace Initiatives Lead to Increased Flu Vaccination – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF CDC: Workplace Initiatives Lead to Increased Flu Vaccination – APhA submits compounding comments to FDA. – (866) 348-2889. All health care professionals should receive an annual influenza vaccine to both prevent … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Approves New Epinephrine Product for Children – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Approves New Epinephrine Product for Children – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA have approved another new epinephrine auto-injector. Admais’ 0.15mg Symjepi is … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off